ureter cancer

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urological Malignancies, Prostate Cancer, Renal Cell Cancer Trial in Seoul

Recruiting
  • Urological Malignancies
  • +4 more
    • Seoul, Korea, Republic of
      Yonsei Severance Hospital
    Jan 30, 2023

    Primary and Metastatic Tumors in Renal Cell Carcinoma and

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Immune checkpoint inhibitor targeting PD1
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Jan 27, 2023

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    A Genotype-Phenotype Urothelial Cancer Registry

    Recruiting
    • Urothelial Cancer
    • +3 more
    • saliva sample and questionaire
    • saliva sample, questionaire
    • Basking Ridge, New Jersey
    • +3 more
    Jun 2, 2022

    Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

    Recruiting
    • Pancreatic Cancer
    • +49 more
      • Colorado Springs, Colorado
      • +80 more
      Feb 22, 2022

      Urothelial Carcinoma, Kidney Cancer, Ureter Cancer Trial in Toronto (drug, other, dietary supplement)

      Completed
      • Urothelial Carcinoma
      • +3 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Nov 22, 2021

      Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,

      Recruiting
      • Distal Urethral Cancer
      • +8 more
      • afatinib dimaleate
      • laboratory biomarker analysis
      • Atlanta, Georgia
      • +5 more
      Sep 24, 2021

      Prostate Cancer, Renal Cell Cancer, Bladder Cancer Trial in Seoul

      Recruiting
      • Prostate Cancer
      • +3 more
        • Seoul, Korea, Republic of
          Department of Urology, Urological Science Institute, Yonsei Univ
        Dec 10, 2019

        Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Ureter Cancer Trial in United Kingdom (carboplatin,

        Completed
        • Bladder Cancer
        • +3 more
        • Glasgow, Scotland, United Kingdom
        • +20 more
        May 14, 2019

        CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma

        Completed
        • Urinary Tract Cancer
        • +2 more
          • Amsterdam, Netherlands
            Academic Medical Center
          Jun 5, 2018

          Bladder Cancer, Ureter Cancer, Urethral Cancer Trial in Korea, Republic of (Treatment duration of cisplatin based chemo)

          Unknown status
          • Bladder Cancer
          • +3 more
          • Treatment duration of cisplatin based chemotherapy
          • Yangsan, Gyeongsangnam-do, Korea, Republic of
          • +18 more
          Sep 23, 2017

          Bladder Cancer, Ureter Cancer, Transitional Cell Carcinoma Trial in Korea, Republic of (pemetrexed, Folic Acid, Vitamin B12

          Unknown status
          • Bladder Cancer
          • +2 more
          • Anyang, Korea, Republic of
          • +20 more
          Jun 18, 2017

          Urothelial Carcinoma, Ureteral Tumors, Ureter Cancer Trial run by the NCI (TRC105)

          Completed
          • Urothelial Carcinoma
          • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Nov 16, 2016

          Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer Trial in United States (Cisplatin, Gemcitabine, ALT-801)

          Unknown status
          • Transitional Cell Carcinoma of Bladder
          • +3 more
          • Tucson, Arizona
          • +15 more
          Apr 11, 2016

          Bladder Cancer, Renal Pelvis Cancer, Ureter Cancer Trial in New York (gemcitabine and split-dose cisplatin plus escalating doses

          Completed
          • Bladder Cancer
          • +2 more
          • gemcitabine and split-dose cisplatin plus escalating doses of continuous Everolimus (RAD001)
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Mar 29, 2016

          Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

          Completed
          • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
          • +9 more
          • San Francisco, California
            UCSF-Mount Zion
          Jun 4, 2013

          Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Transitional Cell Carcinoma of the

          Completed
          • Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
          • +3 more
          • arsenic trioxide
          • Chicago, Illinois
            Cancer and Leukemia Group B
          Jun 3, 2013

          Bladder Cancer, Ureter Cancer Trial in Seoul (Genexol PM)

          Completed
          • Bladder Cancer
          • Ureter Cancer
          • Genexol PM
          • Seoul, Korea, Republic of
            Asan Medical Center
          Dec 6, 2011

          Bladder Cancer, Transitional Cell Bladder Cancer, Urethra Cancer Trial in Worldwide (AZD4877)

          Completed
          • Bladder Cancer
          • +4 more
          • Palo Alto, California
          • +35 more
          Dec 13, 2010